Standout Papers

Revised Response Criteria for Malignant Lymphoma 2001 2026 2009 2017 3.1k
  1. Revised Response Criteria for Malignant Lymphoma (2007)
    Bruce D. Cheson, Beate Pfistner et al. Journal of Clinical Oncology
  2. Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study (2001)
    Allan T. van Oosterom, Ian Judson et al. The Lancet
  3. Use of Positron Emission Tomography for Response Assessment of Lymphoma: Consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma (2007)
    Malik E. Juweid, Sigrid Stroobants et al. Journal of Clinical Oncology

Immediate Impact

3 by Nobel laureates 6 from Science/Nature 81 standout
Sub-graph 1 of 15

Citing Papers

HIFs, angiogenesis, and metabolism: elusive enemies in breast cancer
2020 Standout
ImmunoPET: Concept, Design, and Applications
2020 Standout
45 intermediate papers

Works of Sigrid Stroobants being referenced

Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR trial
2015
Synthesis and in vivo preclinical evaluation of an 18F labeled uPA inhibitor as a potential PET imaging agent
2014
and 11 more

Author Peers

Author Last Decade Papers Cites
Sigrid Stroobants 6286 5794 1224 4771 235 14.9k
Andreas K. Buck 7399 4563 2042 2110 423 16.4k
Otto S. Hoekstra 10498 6847 1269 3166 364 19.6k
Heiko Schöder 7405 4759 977 2439 324 14.2k
Eli Glatstein 2379 10640 1758 5198 355 20.0k
Eva Wardelmann 2610 3992 1412 1741 287 10.2k
Rodney J. Hicks 11043 8303 1964 2788 590 23.2k
Gerald Antoch 7907 4447 427 894 485 13.6k
Ken Herrmann 10054 9388 1488 612 571 18.1k
Daniel T. Chang 2360 4341 1168 1007 349 11.6k
Giovanni Paganelli 5697 2623 1192 5891 351 18.3k

All Works

Loading papers...

Rankless by CCL
2026